← 홈

고형암 (전체)

911개 · ADC 1068 · Antibody 5456 · CGT 2744 · 다음 갱신 D-13 · 마지막 7월 13일

인기최근 업데이트큐레이션임상 많은갱신 필요ORR최신Phase 3FDA승인프로그램 911개
ADCBiologicstaleCancer Institute and Hospital, …Phase 2

IDOV-SAFE (IDOV-SAFE)

Rare Malignant Neoplasm; Advanced Solid Tumors · Rare Malignant Neoplasm

#RareMalignantNeoplasm#ADC#Phase2#항체약물접합체#antibody-drug-conjugate+2
임상시험 3상태 RECRUITING
CGTBiologicstaleBeijing Immunochina Medical Sci…Phase 1

IM96 CAR-T cells (IM96 CAR-T cells)

Adenocarcinoma of Gastric; Adenocarcinoma of Esophagogastric Junction · Advanced Solid Tumors

#AdvancedSolidTumors#CGT#Phase1#세포유전치료#CAR-T+4
임상시험 3상태 RECRUITING
CGTBiologicstalePeter MacCallum Cancer Centre, …Phase 1

LeY CAR T cells (LeY CAR T cells)

Advanced Cancer · Advanced Cancer

#AdvancedCancer#CGT#Phase1#세포유전치료#CAR-T+2
임상시험 3상태 ACTIVE
AntibodystaleBristol Myers SquibbPhase 2

Niraparib + Ipilimumab (Niraparib + Ipilimumab)

Pancreatic Adenocarcinoma · Pancreatic Adenocarcinoma

#PancreaticAdenocarcinoma#Antibody#Phase2#항체#면역항체+2
효능 ORR 7.7%임상시험 3상태 ACTIVE
ADCBiologicstaleMedical Research CouncilPhase 1

Paclitaxel/Docetaxel/Ifosfamide (Paclitaxel/Docetaxel/Ifosfamide)

Muscle Invasive Bladder Urothelial Carcinoma · Muscle Invasive Bladder Urothelial Carci

#MuscleInvasiveBladderUrothelialC#ADC#Phase1#항체약물접합체#antibody-drug-conjugate+1
효능 ORR 0%임상시험 3상태 ACTIVE
ADCBiologicstaleCancer Institute and Hospital, …Phase 2

QH101 (QH101)

Rare Malignant Neoplasm; Advanced Solid Tumors · Rare Malignant Neoplasm

#RareMalignantNeoplasm#ADC#Phase2#항체약물접합체#antibody-drug-conjugate+2
임상시험 3상태 RECRUITING
AntibodyRochePhase 2

disitamab vedotin (Disitamab Vedotin, RC48, RC48+carboplatin±bevacizumab)

Ovarian Cancer Metastatic; Ovarian Cancer Metastatic Recurrent · Ovarian Carcinoma

#OvarianCarcinoma#Antibody#Phase2#항체#면역항체+4
임상시험 3상태 RECRUITING
ADCBiologicstaleTORL Biotherapeutics, LLCPhase 1

TORL-1-23 (TORL-1-23)

Advanced Solid Tumor; Ovarian Cancer · Advanced Solid Tumor

#AdvancedSolidTumor#ADC#Phase1#항체약물접합체#antibody-drug-conjugate+2
임상시험 3상태 RECRUITING
AntibodystaleGenentech, Inc.Phase 1

XmAb24306 (XmAb24306)

Solid Tumors · Solid Tumors

#SolidTumors#Antibody#Phase1#항체#면역항체+2
임상시험 3상태 ACTIVE
AntibodystaleRochePreclinical

atezolizumab (Tecentriq, atezolizumab plus bevacizumab)

Hepatocellular Carcinoma; Hepatic Portal Vein Tumor Invasion · Advanced Hepatocellular Carcinoma

#AdvancedHepatocellularCarcinoma#Antibody#Preclinical#항체#면역항체+4
효능 ORR 49.3%임상시험 3상태 ACTIVE
CGTBiologicstaleTmunity Therapeutics, a wholly …Phase 1

huCART-meso cells (huCART-meso cells)

Lung Adenocarcinoma; Ovarian Cancer · Pancreatic Cancer

#PancreaticCancer#CGT#Phase1#세포유전치료#CAR-T+4
효능 ORR 0%임상시험 3상태 DISCONTINUED
ADCBiologicstaleMacroGenicsPhase 2

vobramitamab duocarmazine (vobramitamab duocarmazine)

Squamous Cell Carcinoma of Head and Neck; Triple Negative Breast Cancer · Advanced Solid Tumor

#AdvancedSolidTumor#ADC#Phase2#항체약물접합체#antibody-drug-conjugate+3
효능 ORR 45.8%임상시험 3상태 DISCONTINUED
ADCBiologicMultitude Therapeutics Inc.Phase 2

AMT-676 (AMT-676)

Colorectal Cancer · Advanced Solid Tumors

#AdvancedSolidTumors#ADC#Phase2#항체약물접합체#antibody-drug-conjugate+2
임상시험 2상태 RECRUITING
ADCBiologicstalePeking Union Medical CollegePhase 2

AR,AR antagonist +goserelin +docetaxel (AR,AR antagonist +goserelin +docetaxel)

Salivary Gland Carcinoma; Precision Therapy · Salivary Gland Carcinoma

#SalivaryGlandCarcinoma#ADC#Phase2#항체약물접합체#antibody-drug-conjugate+2
임상시험 2상태 RECRUITING
CGTBiologicAstraZenecaPreclinical

AZD0754 (AZD0754)

Hepatocellular Carcinoma; Prostate Cancer · Hepatocellular Carcinoma

#HepatocellularCarcinoma#CGT#Preclinical#세포유전치료#CAR-T+4
임상시험 2상태 RECRUITING
ADCBiologicstaleAstraZenecaPhase 2

AZD3470 (AZD3470)

Advanced Solid Tumors That Are MTAP Deficient · Advanced Solid Tumors That Are MTAP Defi

#AdvancedSolidTumorsThatAreMTAPDe#ADC#Phase2#항체약물접합체#antibody-drug-conjugate+1
임상시험 2상태 RECRUITING
ADCBiologicstalePresage BiosciencesPhase 1

AZD9592 (AZD9592)

Head and Neck Squamous Cell Carcinoma · Advanced Solid Tumours

#AdvancedSolidTumours#ADC#Phase1#항체약물접합체#antibody-drug-conjugate+2
임상시험 2상태 ACTIVE
AntibodyDwight OwenPhase 1

Adenosine A2B Receptor Antagonist PBF-1129 (Adenosine A2B Receptor Antagonist PBF-1129)

Metastatic Lung Non-Small Cell Carcinoma; Recurrent Lung Non-Small Cell Carcinoma · Metastatic Lung Non-Small Cell Carcinoma

#MetastaticLungNon-SmallCellCarci#Antibody#Phase1#항체#면역항체+3
임상시험 2상태 RECRUITING
AntibodystaleJiangsu HengruiPhase 2

Albumin-paclitaxel + carboplatin + apatinib + camrelizumab (Albumin-paclitaxel + carboplatin + apatinib + camrelizumab)

Salivary Gland Carcinoma; Precision Therapy · Salivary Gland Carcinoma

#SalivaryGlandCarcinoma#Antibody#Phase2#항체#면역항체+3
임상시험 2상태 RECRUITING
AntibodystaleRocheApproved

atezolizumab (Tecentriq, Atezolizumab Injection [Tecentriq])

Hepatocellular Carcinoma · Lung Neoplasm Malignant

#LungNeoplasmMalignant#Antibody#Approved#항체#면역항체+3
임상시험 2상태 ACTIVE

15 / 46 페이지

← 이전다음 →